Lawrence Bruno - Core Laboratories Chairman

CLB
 Stock
  

USD 19.83  0.02  0.10%   

  Chairman
Mr. Lawrence V. Bruno was appointed as President, Chief Operating Officer of Core Laboratories N.V. Effective January 1, 2019. He served as Vice President Reservoir Description of the Company between July 2015 and February 1, 2018. Prior to becoming Vice President Reservoir Description, Mr. Bruno was the General Manager of U.S. Rocks from 1999 to July 2015. Prior to joining the Company, he was employed at an oil and gas service company for 14 years before it was acquired by Core Laboratories in 1999
Age: 61  Chairman Since 2020      
31 20 420 3191  https://www.corelab.com
Bruno received a MS degree in Geology in 1987 from the University of Houston.

Core Laboratories Management Efficiency

Core Laboratories has Return on Asset of 3.39 % which means that on every $100 spent on asset, it made $3.39 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 6.51 %, implying that it generated $6.51 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Average Assets is expected to grow to 0.0349. The current year Return on Average Equity is expected to grow to 0.14. Core Laboratories Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 189.06 Million. The current year Assets Non Current is expected to grow to about 433 M, whereas Total Assets are forecasted to decline to about 571.3 M.
The company has 250.85 M in debt with debt to equity (D/E) ratio of 1.51, which is OK given its current industry classification. Core Laboratories has a current ratio of 1.99, which is typical for the industry and considered as normal. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core Laboratories to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

CHAIRMAN Since

Ian ReadPfizer Inc
2018
Edward BreenDupont Denemours
2020
Randall StephensonATT Inc
2020
Ahmet KentCoca-Cola
2017
Michael Roman3M Company
2019
John GrempTechnipFMC Plc
2016
Dan HeintzelmanGeneral Electric
2013
Edgar SiaDupont Denemours
N/A
John RiceGeneral Electric
2010
Thierry PilenkoTechnipFMC Plc
2017
Donald UmplebyCaterpillar
2018
Douglas OberhelmanCaterpillar
2010
Tony CaktiongDupont Denemours
N/A
Muhtar KentCoca-Cola
2009
James QuinceyCoca-Cola
2019
Jeffrey ImmeltGeneral Electric
2017
Keith SherinGeneral Electric
2013
Russell StokesGeneral Electric
2018
Douglas PferdehirtTechnipFMC Plc
2019
H CulpGeneral Electric
2018
Lawrence CulpGeneral Electric
2018
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories operates under Oil Gas Equipment Services classification in the United States and is traded on New York Stock Exchange. It employs 3600 people. Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in Van Heuven Goedhartlaan 7 B and employs 3,600 people. Core Laboratories is listed under Petroleum and Natural category by Fama And French industry classification.

Core Laboratories Leadership Team

Elected by the shareholders, the Core Laboratories' board of directors comprises two types of representatives: Core Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core Laboratories. The board's role is to monitor Core Laboratories' management team and ensure that shareholders' interests are well served. Core Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Tahera Khan, Vice President Human Resources
Gwendolyn Schreffler, Senior Vice President, Corporate Development and Investor Relations
Lawrence Bruno, Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
Monique Eeuwijk, Non-Executive Independent Member of the Supervisory Board
D Ogren, Member of the Supervisory Board
Michael Flecker, Vice President Production Enhancement
Christopher Hill, Chief Financial Officer, Senior Vice President
Alastair Crombie, Vice President Reservoir Description
Mark Elvig, Senior Vice President, Secretary, and General Counsel
Harvey Klingensmith, Non-Executive Independent Member of the Supervisory Board
Michael Straughen, Non-Executive Independent Member of the Supervisory Board
John Ogren, Member of the Supervisory Board
Charles Dunlap, Independent Member of the Board of Supervisory Directors
Monty Davis, COO and Sr. VP
David Hume, Vice President Reservoir Description
J Dumas, Vice President Business Development
Martha Carnes, Presiding Non-Executive Lead Independent Member of the Supervisory Board
Richard Bergmark, CFO, Executive VP and Supervisory Director
Kevin Daniels, Vice President, Chief Accounting Officer
James Gresham, Senior Vice President Business Development
David Demshur, Independent Chairman of the Board of Supervisory Directors and Chief Executive Officer
Kwaku Temeng, Non-Executive Independent Member of the Supervisory Board
Michael Kearney, Independent Supervisory Director
Peter Boks, Vice President Reservoir Description
Gregory Barnett, Non-Executive Independent Member of the Supervisory Board
Chris Hill, Chief Accounting Officer and VP
Margaret Kempen, Independent Member of the Board of Supervisory Directors
Lucia Geuns, Independent Member of the Board of Supervisory Directors
Jeffrey West, Vice President Production Enhancement
Mark Tattoli, Senior Vice President General Counsel, Secretary
Dumas, Vice President Business Development
Gwendolyn Gresham, Senior Vice President Corporate Development and Investor Relations
Jan Sodderland, Independent Member of the Board of Supervisory Directors

Core Laboratories Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Core Laboratories Investors Sentiment

The influence of Core Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Core Laboratories. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Core Laboratories Implied Volatility

    
  98.65  
Core Laboratories' implied volatility exposes the market's sentiment of Core Laboratories NV stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Core Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Core Laboratories stock will not fluctuate a lot when Core Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Current Sentiment - CLB

Core Laboratories Investor Sentiment

Greater number of Macroaxis users are currently bullish on Core Laboratories NV. What is your opinion about investing in Core Laboratories NV? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Core Laboratories Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Core Laboratories information on this page should be used as a complementary analysis to other Core Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Core Laboratories Stock analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.81
Market Capitalization
918.6 M
Quarterly Revenue Growth YOY
0.064
Return On Assets
0.0339
Return On Equity
0.0651
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.